Chemoinformaics analysis of 2-(2-Propenyl)-Delta-Piperideine
| Molecular Weight | 123.199 | nRot | 2 |
| Heavy Atom Molecular Weight | 110.095 | nRig | 7 |
| Exact Molecular Weight | 123.105 | nRing | 1 |
| Solubility: LogS | -1.803 | nHRing | 1 |
| Solubility: LogP | 2.132 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 23.1283 |
| nHD | 0 | BPOL | 14.1817 |
| QED | 0.499 |
| Synth | 3.286 |
| Natural Product Likeliness | 0.929 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.008 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.413 |
| MDCK | 0.0000246 |
| BBB | 0.997 |
| PPB | 0.855838 |
| VDSS | 1.216 |
| FU | 0.127416 |
| CYP1A2-inh | 0.361 |
| CYP1A2-sub | 0.635 |
| CYP2c19-inh | 0.062 |
| CYP2c19-sub | 0.507 |
| CYP2c9-inh | 0.017 |
| CYP2c9-sub | 0.343 |
| CYP2d6-inh | 0.197 |
| CYP2d6-sub | 0.903 |
| CYP3a4-inh | 0.063 |
| CYP3a4-sub | 0.289 |
| CL | 8.368 |
| T12 | 0.641 |
| hERG | 0.016 |
| Ames | 0.016 |
| ROA | 0.46 |
| SkinSen | 0.822 |
| Carcinogencity | 0.831 |
| EI | 0.983 |
| Respiratory | 0.958 |
| NR-Aromatase | 0.014 |
| Antiviral | No |
| Prediction | 0.954834 |